Bespak is a global contract development and manufacturing organisation (CDMO) focused on inhaled and nasal drug delivery devices and drug-device combination products. Bespak develops and manufactures finished pharmaceutical products, as well as being a leading global supplier of drug delivery devices and componentry to the pharmaceutical industry. With a long history in the development and commercial supply of pressurised Metered Dose Inhalers (pMDIs), Bespak supplies a major proportion of the world’s pMDI dosing valves and actuators, and also specialises in the industrialisation and high-volume manufacture of complex dry powder inhaler (DPI) devices. Headquartered in Holmes Chapel, UK, the company’s service offering spans early-stage feasibility, analytical and product development, through pilot-scale, clinical and commercial-scale drug product fill-finish, to device and component manufacturing.
Looking for a particular Bespak employee's phone or email?
The Bespak annual revenue was $37.6 million in 2026.
Chris Hirst is the CEO of Bespak.
382 people are employed at Bespak.
Bespak is based in Holmes Chapel, England.
The NAICS codes for Bespak are [334, 339, 33].
The SIC codes for Bespak are [382, 38, 384].